Regn475/sar164877 (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 298 | Hereditary pancreatitis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01001923 (ClinicalTrials.gov) | December 2009 | 26/10/2009 | Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain | Randomized, Double-blind, Placebo-controlled Study of the Effect of a Single Injection of SAR164877 (REGN475) on Reduction of Pain From Chronic Pancreatitis | Abdominal Pain Upper | Drug: REGN475/SAR164877;Drug: Placebo (for REGN475/SAR164877) | Regeneron Pharmaceuticals | NULL | Terminated | 18 Years | 80 Years | Both | 15 | Phase 2 | United States |